-
Mashup Score: 18
Nuru Noor (University of Cambridge) discusses the PROFILE trial of biomarker-stratified treatment strategies in people with newly diagnosed Crohn’s disease.Read the full article:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00034-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas
Source: www.buzzsprout.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 33The Lancet Gastroenterology and Hepatology: Homepage - 4 day(s) ago
Discover articles from The Lancet Gastroenterology & Hepatology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally
Source: www.thelancet.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 3Rob Brierley on LinkedIn: #worldhepatitissummit #gastroenterology #hepatology #medicine - 4 day(s) ago
The June issue of The Lancet Gastroenterology & Hepatology is out now at https://lnkd.in/eACvnEez! This month’s cover, by Marta Lanuza, focuses on one of the…
Source: www.linkedin.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 33The Lancet Gastroenterology and Hepatology: Homepage - 4 day(s) ago
Discover articles from The Lancet Gastroenterology & Hepatology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally
Source: www.thelancet.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 19Low anti-TNF concentrations at week 14 linked to long-term loss of response in Crohn’s - 5 day(s) ago
Approximately two-thirds of patients with Crohn’s disease who initially responded to anti-tumor necrosis factor therapy lost response by 3 years, with researchers suggesting that higher drug concentrations at induction may improve outcomes. “Anti-TNF treatment failure is common, with a quarter of patients having primary nonresponse and a third of initial responders losing
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 12
Maralixibat improved pruritus and predictors of native liver survival in PFIC (eg, serum bile acids). Maralixibat represents a non-surgical, pharmacological option to interrupt the enterohepatic circulation and improve the standard of care in patients with PFIC.
Source: www.thelancet.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 45
A no-drain policy is safe in terms of major morbidity and reduced the detection of grade B or C POPF, and should be the new standard approach in eligible patients undergoing distal pancreatectomy.
Source: www.thelancet.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 15
On April 17, 2024, Scotland’s Parliament approved a 30% increase to the price per unit of alcohol sold in the country. The ruling means the minimum unit price (MUP) will rise from ÂŁ0·50 per unit to ÂŁ0·65 from this September.
Source: www.thelancet.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 2U.S. Lags Behind Other Countries in Hepatitis-C Treatment - 14 day(s) ago
Despite an arsenal of drugs, many Americans are still unaware of their infections until it’s too late. A Biden initiative languishes without Congressional approval.
Source: www.nytimes.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 6Dietary Interventions Beat Medication in IBS Treatment - 18 day(s) ago
Both a low-FODMAPs and low-carb diet led to a larger decrease in symptom severity
Source: www.medpagetoday.comCategories: General Medicine News, GastroenterologyTweet
New podcast online🎙️ We spoke to Nuru Noor about the genesis and findings of the PROFILE RCT (@ProfileCrohn), which found a benefit of very early treatment with combined anti-TNF & immunomodulator in #Crohns disease Listen🔊https://t.co/qOId8UrKmF 📜https://t.co/JTuHVWaTSV https://t.co/CffiWE5Yqd